Table 2 |
|||
|
Final docked energies for DHFR inhibitors. |
|||
|
DHFR sequence |
Pyrimethamine |
Cycloguanil |
Trimethoprim |
|
|
|||
|
WT P. falciparum |
-11.04 |
-10.88 |
-11.32 |
|
WT P. vivax |
-10.60 |
-10.63 |
-10.87 |
|
WT P. ovale |
-10.50 |
-10.54 |
-10.52 |
|
WT P. malariae |
-10.60 |
-10.64 |
-10.93 |
|
Mutant P. malariae |
|||
|
N50K |
-10.88 (-0.28) |
-10.40 (+0.24) |
-10.76 (+0.17) |
|
S114N |
-10.93 (-0.33) |
-10.21 (+0.43) |
-10.38 (+0.55) |
|
I170M |
-8.62 (+1.98) |
-7.87 (+2.77) |
-9.83 (+1.10) |
|
|
|||
|
Results are based on the Autodock 3.0.5 program; values are kcal/mol. For PmDHFR mutants, relative binding energies (ΔΔG) are shown in brackets (reduction in binding produces a positive ΔΔG and enhanced binding produces a negative ΔΔG). |
|||
|
Choowongkomon et al. Malaria Journal 2010 9:65 doi:10.1186/1475-2875-9-65 |
|||